Clinical Trial Update: Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating brexpiprazole as an adjunctive treatment for sleep disturbances in major depressive disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Sleep Disturbances

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Sleep Disturbances | Phase 3 | Status: COMPLETED | Results posted: 2016-03-01